论文部分内容阅读
Ａｍｇｅｎ公司的血小板因子开始临床试验为了减少癌症化疗后导致的严重和持续的血小板减少，阿姆吉（Ａｍｇｅｎ）公司已开始巨核细胞生长和发育因子（ＭＧＤＦ）的临床试验，以期用ＭＧＤＦ刺激血小板的生成。现正与日本麒麟麦酒公司合作开发ＭＧＤＦ．在开发血小板生长...
Amgen’s Platelet Factor Launches Clinical Trials Amgen has begun clinical trials of megakaryocyte growth and developmental factor (MGDF) in order to reduce severe and persistent thrombocytopenia after cancer chemotherapy in order to stimulate the platelet-rich generate. MGDF is being developed in cooperation with Kirin Brewery Company of Japan. In the development of platelet growth ...